Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis. - Makaro, Adam; Świerczyński, Mikołaj; Pokora, Kacper; Sarniak, Barbara; Kordek, Radzisław; Fichna, Jakub; Salaga, Maciej (Inflammopharmacology, 2024)